NYSE:BIRK

Birkenstock (BIRK) Stock Price, News & Analysis

$45.45
+0.61 (+1.36%)
(As of 04/26/2024 ET)
Today's Range
$45.04
$46.12
50-Day Range
$41.99
$52.00
52-Week Range
$35.83
$55.00
Volume
392,818 shs
Average Volume
745,406 shs
Market Capitalization
$8.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$49.15

Birkenstock MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.58 Rating Score
Upside/​Downside
8.1% Upside
$49.15 Price Target
Short Interest
Bearish
20.65% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.43mentions of Birkenstock in the last 14 days
Based on 19 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
37.50%
From $1.28 to $1.76 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.78 out of 5 stars

Consumer Discretionary Sector

243rd out of 266 stocks

Footwear, Except Rubber Industry

6th out of 6 stocks

BIRK stock logo

About Birkenstock Stock (NYSE:BIRK)

Birkenstock Holding plc manufactures and sells footwear products. It also offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories. The company sells its products through e-commerce sites and a network of owned retail stores, as well as business-to-business channels. It operates in the United States, Brazil, Canada, Mexico, Europe, APMA, and internationally. Birkenstock Holding plc was founded in 1774 and is based in London, the United Kingdom. Birkenstock Holding plc is a subsidiary of BK LC Lux MidCo S.à r.l.

BIRK Stock Price History

BIRK Stock News Headlines

Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
See More Headlines
Receive BIRK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Birkenstock and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
4/26/2024
Next Earnings (Confirmed)
5/30/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Footwear, except rubber
Sub-Industry
N/A
Fax
N/A
Employees
6,300
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$49.15
High Stock Price Target
$61.00
Low Stock Price Target
$37.15
Potential Upside/Downside
+8.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.58
Research Coverage
19 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.62 billion
Cash Flow
$0.93 per share
Book Value
$13.66 per share

Miscellaneous

Free Float
N/A
Market Cap
$8.54 billion
Optionable
Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Oliver Reichert (Age 53)
    CEO & Director
  • Dr. Erik Massmann (Age 59)
    Chief Financial Officer
  • Volker Bach
    Vice President of Global Accounting
  • Mr. Mark Jensen (Age 41)
    Chief Technical Operations Officer
  • Mr. Christian Heesch (Age 51)
    Chief Legal Officer
  • Mr. Jochen Gutzy (Age 54)
    Chief Communications Officer
  • Mr. Klaus Baumann (Age 55)
    Chief Sales Officer
  • Dr. Markus Baum (Age 46)
    Chief Product Officer
  • Mr. David Kahan (Age 63)
    President of Americas
  • Mr. Mehdi Nico Bouyakhf (Age 49)
    President of Europe

BIRK Stock Analysis - Frequently Asked Questions

Should I buy or sell Birkenstock stock right now?

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Birkenstock in the last twelve months. There are currently 8 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BIRK shares.
View BIRK analyst ratings
or view top-rated stocks.

What is Birkenstock's stock price target for 2024?

19 analysts have issued 1-year price objectives for Birkenstock's shares. Their BIRK share price targets range from $37.15 to $61.00. On average, they predict the company's stock price to reach $49.15 in the next year. This suggests a possible upside of 8.1% from the stock's current price.
View analysts price targets for BIRK
or view top-rated stocks among Wall Street analysts.

How have BIRK shares performed in 2024?

Birkenstock's stock was trading at $48.73 at the beginning of 2024. Since then, BIRK shares have decreased by 6.7% and is now trading at $45.45.
View the best growth stocks for 2024 here
.

Are investors shorting Birkenstock?

Birkenstock saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 5,140,000 shares, an increase of 6.6% from the March 31st total of 4,820,000 shares. Based on an average trading volume of 632,600 shares, the days-to-cover ratio is presently 8.1 days. Approximately 20.7% of the shares of the company are short sold.
View Birkenstock's Short Interest
.

When is Birkenstock's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 30th 2024.
View our BIRK earnings forecast
.

How can I listen to Birkenstock's earnings call?

Birkenstock will be holding an earnings conference call on Thursday, May 30th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 919-882-2331 with passcode "50256".

How were Birkenstock's earnings last quarter?

Birkenstock Holding plc (NYSE:BIRK) announced its earnings results on Thursday, February, 29th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. The company earned $303 million during the quarter, compared to analysts' expectations of $289.09 million. The company's revenue for the quarter was up 21.9% on a year-over-year basis.

What ETFs hold Birkenstock's stock?

ETFs with the largest weight of Birkenstock (NYSE:BIRK) stock in their portfolio include First Trust IPOX Europe Equity Opportunities ETF (FPXE) and Renaissance IPO ETF (IPO).First Trust International Equity Opportunities ETF (FPXI).

When did Birkenstock IPO?

Birkenstock (BIRK) raised $1.5 billion in an initial public offering (IPO) on Wednesday, October 11th 2023. The company issued 32,258,064 shares at a price of $46.00 per share.

When did the company's lock-up period expire?

Birkenstock's lock-up period expired on Monday, April 8th. Birkenstock had issued 32,258,064 shares in its public offering on October 11th. The total size of the offering was $1,483,870,944 based on an initial share price of $46.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

Who are Birkenstock's major shareholders?

Birkenstock's stock is owned by a number of institutional and retail investors. Top institutional investors include Alaska Permanent Fund Corp (0.03%), Simplex Trading LLC (0.00%), Renaissance Capital LLC (0.01%), Venturi Wealth Management LLC (0.00%), CWM LLC (0.00%) and Banque Cantonale Vaudoise (0.00%).

How do I buy shares of Birkenstock?

Shares of BIRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BIRK) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners